Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

A Critique of the AUA Guidelines on Testosterone Deficiency.

Morgentaler A, Traish AM, Khera M.

J Sex Med. 2019 Dec 4. pii: S1743-6095(19)31510-3. doi: 10.1016/j.jsxm.2019.10.019. [Epub ahead of print] No abstract available.

PMID:
31812687
2.
3.

Mechanistic details of amino acid catalyzed two-component Mannich reaction: experimental study backed by density functional calculations.

Rani D, Thakur L, Khera M, Goel N, Agarwal J.

Amino Acids. 2019 Nov;51(10-12):1609-1621. doi: 10.1007/s00726-019-02798-z. Epub 2019 Nov 11.

PMID:
31712920
4.

Effect of Body Weight on Sexual Function in Men and Women.

Bates JN, Pastuszak AW, Khera M.

Curr Sex Health Rep. 2019 Mar;11(1):52-59. Epub 2019 Jan 19.

PMID:
31576197
5.

Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database.

Lopez DS, Huang D, Tsilidis KK, Khera M, Williams SB, Urban RJ, Panagiotou OA, Kuo YF, Baillargeon J, Farias A, Krause T.

Clin Endocrinol (Oxf). 2019 Dec;91(6):885-891. doi: 10.1111/cen.14093. Epub 2019 Oct 7.

PMID:
31498469
6.

Editorial Comment.

Khera M, Sadeghi-Nejad H.

J Urol. 2019 Sep;202(3):610. doi: 10.1097/01.JU.0000569608.72542.41. Epub 2019 Aug 8. No abstract available.

PMID:
31199177
7.

An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress?

Khera M, Bivalacqua T, Goldstein I, Albersen M.

Eur Urol Focus. 2019 Jul;5(4):536-538. doi: 10.1016/j.euf.2019.05.017. Epub 2019 Jun 10.

PMID:
31196678
8.

Paediatric and adult-onset male hypogonadism.

Salonia A, Rastrelli G, Hackett G, Seminara SB, Huhtaniemi IT, Rey RA, Hellstrom WJG, Palmert MR, Corona G, Dohle GR, Khera M, Chan YM, Maggi M.

Nat Rev Dis Primers. 2019 May 30;5(1):38. doi: 10.1038/s41572-019-0087-y. Review.

9.

Testosterone Replacement Therapy Versus Clomiphene Citrate in the Young Hypogonadal Male.

Scovell JM, Khera M.

Eur Urol Focus. 2018 Apr;4(3):321-323. doi: 10.1016/j.euf.2018.07.033. Epub 2018 Aug 18. Review.

PMID:
30131284
10.

The Role of Testosterone Therapy in the Setting of Prostate Cancer.

Rodriguez KM, Pastuszak AW, Khera M.

Curr Urol Rep. 2018 Jun 30;19(8):67. doi: 10.1007/s11934-018-0812-1. Review.

PMID:
29961247
11.

Erectile Dysfunction: AUA Guideline.

Burnett AL, Nehra A, Breau RH, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh J, Khera M, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW.

J Urol. 2018 Sep;200(3):633-641. doi: 10.1016/j.juro.2018.05.004. Epub 2018 May 7.

PMID:
29746858
12.

Caffeine intake is not associated with serum testosterone levels in adult men: cross-sectional findings from the NHANES 1999-2004 and 2011-2012.

Lopez DS, Advani S, Qiu X, Tsilidis KK, Khera M, Kim J, Canfield S.

Aging Male. 2019 Mar;22(1):45-54. doi: 10.1080/13685538.2018.1465912. Epub 2018 Apr 25.

13.

Penile Prosthesis Implantation in Patients With Peyronie's Disease: Results of the PROPPER Study Demonstrates a Decrease in Patient-Reported Depression.

Khera M, Bella A, Karpman E, Brant W, Christine B, Kansas B, Jones L, Kohler T, Bennett N, Rhee E, Henry G.

J Sex Med. 2018 May;15(5):786-788. doi: 10.1016/j.jsxm.2018.02.024. Epub 2018 Apr 10.

PMID:
29653913
14.

The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk.

Miner M, Morgentaler A, Khera M, Traish AM.

Clin Endocrinol (Oxf). 2018 Jul;89(1):3-10. doi: 10.1111/cen.13589. Epub 2018 Apr 14. Review.

PMID:
29486065
15.

In Vitro and In Vivo Activities of DS-2969b, a Novel GyrB Inhibitor, against Clostridium difficile.

Mathur T, Barman TK, Kumar M, Singh D, Kumar R, Khera MK, Yamada M, Inoue SI, Upadhyay DJ, Masuda N.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02157-17. doi: 10.1128/AAC.02157-17. Print 2018 Apr.

16.

Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism.

Grabner M, Hepp Z, Raval A, Tian F, Khera M.

J Sex Med. 2018 Feb;15(2):148-158. doi: 10.1016/j.jsxm.2017.11.225. Erratum in: J Sex Med. 2018 Jul;15(7):1063.

17.

Hypogonadism: Therapeutic Risks, Benefits, and Outcomes.

Sigalos JT, Pastuszak AW, Khera M.

Med Clin North Am. 2018 Mar;102(2):361-372. doi: 10.1016/j.mcna.2017.10.011. Epub 2017 Dec 6. Review.

PMID:
29406064
18.

Inflatable penile prosthesis implant length with baseline characteristic correlations: preliminary analysis of the PROPPER study.

Bennett N, Henry G, Karpman E, Brant W, Jones L, Khera M, Kohler T, Christine B, Rhee E, Kansas B, Bella AJ.

Transl Androl Urol. 2017 Dec;6(6):1167-1174. doi: 10.21037/tau.2017.12.01.

19.

Alternatives to Testosterone Therapy: A Review.

Lo EM, Rodriguez KM, Pastuszak AW, Khera M.

Sex Med Rev. 2018 Jan;6(1):106-113. doi: 10.1016/j.sxmr.2017.09.004. Epub 2017 Nov 27. Review.

PMID:
29174957
20.

Double trouble: Co-occurrence of testosterone deficiency and body fatness associated with all-cause mortality in US men.

Lopez DS, Qiu X, Advani S, Tsilidis KK, Khera M, Kim J, Morgentaler A, Wang R, Canfield S.

Clin Endocrinol (Oxf). 2018 Jan;88(1):58-65. doi: 10.1111/cen.13501. Epub 2017 Nov 20.

21.

Testosterone inhibits the growth of prostate cancer xenografts in nude mice.

Song W, Soni V, Soni S, Khera M.

BMC Cancer. 2017 Sep 7;17(1):635. doi: 10.1186/s12885-017-3569-x.

22.

Testosterone therapy improves erectile function and libido in hypogonadal men.

Rizk PJ, Kohn TP, Pastuszak AW, Khera M.

Curr Opin Urol. 2017 Nov;27(6):511-515. doi: 10.1097/MOU.0000000000000442. Review.

23.

Recent advances in the treatment of erectile dysfunction.

Mobley DF, Khera M, Baum N.

Postgrad Med J. 2017 Nov;93(1105):679-685. doi: 10.1136/postgradmedj-2016-134073. Epub 2017 Jul 27. Review.

PMID:
28751439
24.

Practice Patterns in the Diagnosis and Management of Hypogonadism: A Survey of Sexual Medicine Society of North America Members.

Yafi FA, Haney NM, Anaissie J, DeLay KJ, Trost L, Khera M, Hellstrom WJG.

Urology. 2017 Aug;106:87-95. doi: 10.1016/j.urology.2017.04.036. Epub 2017 May 4.

PMID:
28479477
25.

Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).

Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Khera M.

J Sex Med. 2017 Mar;14(3):297-315. doi: 10.1016/j.jsxm.2016.11.324.

PMID:
28262100
26.

Sexual Rehabilitation After Treatment for Prostate Cancer-Part 1: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).

Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Khera M.

J Sex Med. 2017 Mar;14(3):285-296. doi: 10.1016/j.jsxm.2016.11.325.

PMID:
28262099
27.

Erectile dysfunction, metabolic syndrome, and cardiovascular risks: facts and controversies.

Sanchez E, Pastuszak AW, Khera M.

Transl Androl Urol. 2017 Feb;6(1):28-36. doi: 10.21037/tau.2016.10.01. Review.

28.

Testosterone therapy and prostate cancer.

Pastuszak AW, Rodriguez KM, Nguyen TM, Khera M.

Transl Androl Urol. 2016 Dec;5(6):909-920. doi: 10.21037/tau.2016.08.17. Review.

29.

Clinical Characteristics, Health Care Utilization and Costs Among Men with Primary or Secondary Hypogonadism in a US Commercially Insured Population.

Grabner M, Bodhani A, Khandelwal N, Palli S, Bonine N, Khera M.

J Sex Med. 2017 Jan;14(1):88-97. doi: 10.1016/j.jsxm.2016.10.012. Epub 2016 Dec 8. Erratum in: J Sex Med. 2017 Feb;14(2):284.

30.

Think Like a Hacker.

Khera M.

J Diabetes Sci Technol. 2017 Mar;11(2):207-212. doi: 10.1177/1932296816677576. Epub 2016 Dec 5.

31.

Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).

Khera M, Adaikan G, Buvat J, Carrier S, El-Meliegy A, Hatzimouratidis K, McCullough A, Morgentaler A, Torres LO, Salonia A.

J Sex Med. 2016 Dec;13(12):1787-1804. doi: 10.1016/j.jsxm.2016.10.009. Review.

PMID:
27914560
32.

Editorial Comment on "Couple-Based Psychosexual Support Following Prostate Cancer Surgery: Results of a Feasibility Pilot Randomized Control Trial".

Khera M.

J Sex Med. 2016 Aug;13(8):1243-4. doi: 10.1016/j.jsxm.2016.05.015. No abstract available.

PMID:
27436078
33.

Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction.

Podlasek CA, Mulhall J, Davies K, Wingard CJ, Hannan JL, Bivalacqua TJ, Musicki B, Khera M, González-Cadavid NF, Burnett AL 2nd.

J Sex Med. 2016 Aug;13(8):1183-98. doi: 10.1016/j.jsxm.2016.06.004. Review.

34.

Adult-Onset Hypogonadism.

Khera M, Broderick GA, Carson CC 3rd, Dobs AS, Faraday MM, Goldstein I, Hakim LS, Hellstrom WJ, Kacker R, Köhler TS, Mills JN, Miner M, Sadeghi-Nejad H, Seftel AD, Sharlip ID, Winters SJ, Burnett AL.

Mayo Clin Proc. 2016 Jul;91(7):908-26. doi: 10.1016/j.mayocp.2016.04.022. Epub 2016 Jun 21. Review.

35.

Testosterone Therapies.

Khera M.

Urol Clin North Am. 2016 May;43(2):185-93. doi: 10.1016/j.ucl.2016.01.004. Epub 2016 Mar 18. Review.

PMID:
27132575
36.

Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).

Hatzimouratidis K, Salonia A, Adaikan G, Buvat J, Carrier S, El-Meliegy A, McCullough A, Torres LO, Khera M.

J Sex Med. 2016 Apr;13(4):465-88. doi: 10.1016/j.jsxm.2016.01.016. Epub 2016 Mar 25. Review.

PMID:
27045254
37.

Changing paradigm of men's health.

Khera M.

Indian J Urol. 2016 Jan-Mar;32(1):5. doi: 10.4103/0970-1591.173114. No abstract available.

38.

Testosterone is Protective against Cardiac Disease: Pro.

Khera M.

J Urol. 2016 Apr;195(4 Pt 1):831-2. doi: 10.1016/j.juro.2016.01.085. Epub 2016 Jan 22. No abstract available.

PMID:
26807929
39.

Male hormones and men's quality of life.

Khera M.

Curr Opin Urol. 2016 Mar;26(2):152-7. doi: 10.1097/MOU.0000000000000256. Review.

PMID:
26765046
40.

The Evolution of the Inflatable Penile Prosthesis Reservoir and Surgical Placement.

Hakky T, Lentz A, Sadeghi-Nejad H, Khera M.

J Sex Med. 2015 Nov;12 Suppl 7:464-7. doi: 10.1111/jsm.13011. Review.

PMID:
26565579
41.

Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen.

Pastuszak AW, Gomez LP, Scovell JM, Khera M, Lamb DJ, Lipshultz LI.

Sex Med. 2015 Sep;3(3):165-73. doi: 10.1002/sm2.76. Epub 2015 Aug 12.

42.

Diagnosing secondary hypogonadism: important consequences for fertility and reversibility.

Dean J, Maggi M, de Boer BJ, Hellstrom W, Khera M, Kim ED, McCullough A, Wu F, Zitzmann M.

BJU Int. 2016 Apr;117(4):552-4. doi: 10.1111/bju.13316. Epub 2015 Nov 14. No abstract available.

43.

The Who, How and What of Real-World Penile Implantation in 2015: The PROPPER Registry Baseline Data.

Henry GD, Karpman E, Brant W, Christine B, Kansas BT, Khera M, Jones L, Kohler T, Bennett N, Rhee E, Eisenhart E, Bella AJ.

J Urol. 2016 Feb;195(2):427-33. doi: 10.1016/j.juro.2015.07.109. Epub 2015 Aug 17.

PMID:
26292043
44.

Testosterone Therapy for Female Sexual Dysfunction.

Khera M.

Sex Med Rev. 2015 Jul;3(3):137-144. doi: 10.1002/smrj.53. Epub 2015 Oct 8. Review.

PMID:
27784606
45.

Peyronie's Disease: AUA Guideline.

Nehra A, Alterowitz R, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh JJ, Khera M, Kirkby E, McVary KT, Miner MM, Nelson CJ, Sadeghi-Nejad H, Seftel AD, Shindel AW, Burnett AL; American Urological Association Education and Research, Inc.,.

J Urol. 2015 Sep;194(3):745-53. doi: 10.1016/j.juro.2015.05.098. Epub 2015 Jun 9.

46.

Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer.

Pastuszak AW, Khanna A, Badhiwala N, Morgentaler A, Hult M, Conners WP, Sarosdy MF, Yang C, Carrion R, Lipshultz LI, Khera M.

J Urol. 2015 Nov;194(5):1271-6. doi: 10.1016/j.juro.2015.05.084. Epub 2015 May 27.

PMID:
26025500
47.

Mesenchymal stem cell therapy for the treatment of erectile dysfunction.

Khera M, Albersen M, Mulhall JP.

J Sex Med. 2015 May;12(5):1105-6. doi: 10.1111/jsm.12871. No abstract available.

PMID:
25974235
48.

The nanochannel delivery system for constant testosterone replacement therapy.

Ferrati S, Nicolov E, Zabre E, Geninatti T, Shirkey BA, Hudson L, Hosali S, Crawley M, Khera M, Palapattu G, Grattoni A.

J Sex Med. 2015 Jun;12(6):1375-80. doi: 10.1111/jsm.12897. Epub 2015 Apr 30.

49.

Combined tests of prostate specific antigen and testosterone will improve diagnosis and monitoring the progression of prostate cancer.

Song W, Soni V, Khera M.

Asian J Androl. 2015 Sep-Oct;17(5):807-10. doi: 10.4103/1008-682X.148721.

50.

Erectile dysfunction as a marker for cardiovascular disease diagnosis and intervention: a cost analysis.

Pastuszak AW, Hyman DA, Yadav N, Godoy G, Lipshultz LI, Araujo AB, Khera M.

J Sex Med. 2015 Apr;12(4):975-84. doi: 10.1111/jsm.12848. Epub 2015 Mar 2.

Supplemental Content

Support Center